Cargando…
Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations
OBJECTIVE: Hemophilia A (HA) is the most severe X-linked inherited bleeding disorder caused by hemizygous mutations in the factor 8 (F8) gene. The aim of this study is to determine the mutation spectrum of the F8 gene in a large HA cohort from Turkey, and then to establish a phenotype-genotype corre...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463214/ https://www.ncbi.nlm.nih.gov/pubmed/32026663 http://dx.doi.org/10.4274/tjh.galenos.2020.2019.0262 |
_version_ | 1783577083635564544 |
---|---|
author | Atik, Tahir Işık, Esra Onay, Hüseyin Akgün, Bilçağ Shamsali, Moharram Kavaklo, Kaan Evim, Melike Tüysüz, Gülen Özbek, Namık Yaşar Şahin, Fahri Salcıoğlu, Zafer Albayrak, Canan Oymak, Yeşim Ünal, Ekrem Belen, Fatma Burcu Yılmaz Keskin, Ebru Balkan, Can Baytan, Birol Küpesiz, Alphan Culha, Vildan Tahtakesen Güçer, Tuba Nur Güneş, Adalet Meral Özkınay, Ferda |
author_facet | Atik, Tahir Işık, Esra Onay, Hüseyin Akgün, Bilçağ Shamsali, Moharram Kavaklo, Kaan Evim, Melike Tüysüz, Gülen Özbek, Namık Yaşar Şahin, Fahri Salcıoğlu, Zafer Albayrak, Canan Oymak, Yeşim Ünal, Ekrem Belen, Fatma Burcu Yılmaz Keskin, Ebru Balkan, Can Baytan, Birol Küpesiz, Alphan Culha, Vildan Tahtakesen Güçer, Tuba Nur Güneş, Adalet Meral Özkınay, Ferda |
author_sort | Atik, Tahir |
collection | PubMed |
description | OBJECTIVE: Hemophilia A (HA) is the most severe X-linked inherited bleeding disorder caused by hemizygous mutations in the factor 8 (F8) gene. The aim of this study is to determine the mutation spectrum of the F8 gene in a large HA cohort from Turkey, and then to establish a phenotype-genotype correlation. MATERIALS AND METHODS: All HA cases (270 patients) analyzed molecularly in the Ege University Pediatric Genetics Molecular Laboratory between March 2017 and March 2018 were included in this study. To identify intron 22 inversion (Inv22), intron 1 inversion (Inv1), small deletion/insertions, and point mutations, molecular analyses of F8 were performed using a sequential application of molecular techniques. RESULTS: The mutation detection success rate was 95.2%. Positive Inv22 was found in 106 patients (39.3%), Inv1 was found in 4 patients (1.5%), and 106 different disease-causing sequence variants were identified in 137 patients (50.6%). In 10 patients (3.7%), amplification failures involving one or more exonic regions, considered to be large intragenic deletions, were identified. Of 106 different F8 mutations, 36 were novel. The relationship between F8 genotype and inhibitor development was considered significant. CONCLUSION: A high mutation detection rate was achieved via the broad molecular techniques applied in this study, including 36 novel mutations. With regard to mutation types, mutation distribution and their impact on clinical severity and inhibitor development were found to be similar to those previously reported in other hemophilia population studies. |
format | Online Article Text |
id | pubmed-7463214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-74632142020-09-16 Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations Atik, Tahir Işık, Esra Onay, Hüseyin Akgün, Bilçağ Shamsali, Moharram Kavaklo, Kaan Evim, Melike Tüysüz, Gülen Özbek, Namık Yaşar Şahin, Fahri Salcıoğlu, Zafer Albayrak, Canan Oymak, Yeşim Ünal, Ekrem Belen, Fatma Burcu Yılmaz Keskin, Ebru Balkan, Can Baytan, Birol Küpesiz, Alphan Culha, Vildan Tahtakesen Güçer, Tuba Nur Güneş, Adalet Meral Özkınay, Ferda Turk J Haematol Research Article OBJECTIVE: Hemophilia A (HA) is the most severe X-linked inherited bleeding disorder caused by hemizygous mutations in the factor 8 (F8) gene. The aim of this study is to determine the mutation spectrum of the F8 gene in a large HA cohort from Turkey, and then to establish a phenotype-genotype correlation. MATERIALS AND METHODS: All HA cases (270 patients) analyzed molecularly in the Ege University Pediatric Genetics Molecular Laboratory between March 2017 and March 2018 were included in this study. To identify intron 22 inversion (Inv22), intron 1 inversion (Inv1), small deletion/insertions, and point mutations, molecular analyses of F8 were performed using a sequential application of molecular techniques. RESULTS: The mutation detection success rate was 95.2%. Positive Inv22 was found in 106 patients (39.3%), Inv1 was found in 4 patients (1.5%), and 106 different disease-causing sequence variants were identified in 137 patients (50.6%). In 10 patients (3.7%), amplification failures involving one or more exonic regions, considered to be large intragenic deletions, were identified. Of 106 different F8 mutations, 36 were novel. The relationship between F8 genotype and inhibitor development was considered significant. CONCLUSION: A high mutation detection rate was achieved via the broad molecular techniques applied in this study, including 36 novel mutations. With regard to mutation types, mutation distribution and their impact on clinical severity and inhibitor development were found to be similar to those previously reported in other hemophilia population studies. Galenos Publishing 2020-09 2020-08-28 /pmc/articles/PMC7463214/ /pubmed/32026663 http://dx.doi.org/10.4274/tjh.galenos.2020.2019.0262 Text en © Copyright 2020 by Turkish Society of Hematology / Turkish Journal of Hematology, Published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Atik, Tahir Işık, Esra Onay, Hüseyin Akgün, Bilçağ Shamsali, Moharram Kavaklo, Kaan Evim, Melike Tüysüz, Gülen Özbek, Namık Yaşar Şahin, Fahri Salcıoğlu, Zafer Albayrak, Canan Oymak, Yeşim Ünal, Ekrem Belen, Fatma Burcu Yılmaz Keskin, Ebru Balkan, Can Baytan, Birol Küpesiz, Alphan Culha, Vildan Tahtakesen Güçer, Tuba Nur Güneş, Adalet Meral Özkınay, Ferda Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations |
title |
Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations |
title_full |
Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations |
title_fullStr |
Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations |
title_full_unstemmed |
Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations |
title_short |
Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations |
title_sort | factor 8 gene mutation spectrum of 270 patients with hemophilia a: identification of 36 novel mutations |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463214/ https://www.ncbi.nlm.nih.gov/pubmed/32026663 http://dx.doi.org/10.4274/tjh.galenos.2020.2019.0262 |
work_keys_str_mv | AT atiktahir factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT isıkesra factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT onayhuseyin factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT akgunbilcag factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT shamsalimoharram factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT kavaklokaan factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT evimmelike factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT tuysuzgulen factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT ozbeknamıkyasar factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT sahinfahri factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT salcıogluzafer factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT albayrakcanan factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT oymakyesim factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT unalekrem factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT belenfatmaburcu factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT yılmazkeskinebru factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT balkancan factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT baytanbirol factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT kupesizalphan factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT culhavildan factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT tahtakesengucertubanur factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT gunesadaletmeral factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations AT ozkınayferda factor8genemutationspectrumof270patientswithhemophiliaaidentificationof36novelmutations |